Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.

US Interior Secretary Doug Burgum Talks US Energy Production
14:53

Nobel Laureate & CUNY Economics Professor Paul Krugman Talks Powell Investigation
06:04

Burlington CEO Michael O'Sullivan Talks Growth, Consumer Sentiment
10:04